Table 1 Baseline characteristics
Certoparin (n = 59) | Placebo (n = 58) | ||
|---|---|---|---|
Age (years) | Mean ± SD | 60.0 ± 10.0 | 57.5 ± 11.2 |
Min | 41 | 31 | |
Max | 78 | 79 | |
Gender (%) | Male | 83.1 | 86.2 |
Race | Caucasean | 52 | 51 |
Black | 5 | 7 | |
Hispanic | 2 | 0 | |
K+ at baseline (mmol/l) | Mean ± SD | 4.2 ± 0.4 | 4.3 ± 0.4 |
Min | 3.4 | 3.5 | |
Max | 5.4 | 5.0 | |
Diabetes mellitus (%) | 28.8 | 19.0 | |
Blood urea (mmol/l) | Mean ± SD | 16.5 ± 5.3 | 16.0 ± 5.6 |
Min | 7.0 | 7.0 | |
Max | 31.0 | 37.0 | |
Serum creatinine (mg/dl) | Mean ± SD | 1.1 ± 0.2 | 1.1 ± 0.3 |
Min | 0.7 | 0.7 | |
Max | 1.6 | 2.0 | |
eGFR (ml/min) | Mean ± SD | 95.7 ± 35.5 | 97.5 ± 32.7 |
Min | 43.2 | 41.81 | |
Max | 208.06 | 186.48 | |